DRKS00009029
Recruiting
Not Applicable
Detection of circulating tumor-DNA as a 'liquid biopsy' in patients with Ewing Sarcoma and PNET: a pilot study - /
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ewing-Sarcoma (C41.9)primitive neuroectodermal tumor (C71.9)
- Sponsor
- niversitätsklinikum Freiburg
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Ewing\-Sarcoma /PNET
Exclusion Criteria
- •other malign tumors, systemic diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Detection of circulating tumor DNA by droplet digital PCR in patients with unresectable or recurrent gastric cancergastric cancerJPRN-UMIN000026605Second Department of Surger, Wakayama medical university, School of Medicine20
Recruiting
Not Applicable
oninvasive detection of circulating tumor DNA for disease classification and monitoring in patients with brain tumors.C71C72Malignant neoplasm of brainMalignant neoplasm of spinal cord, cranial nerves and other parts of central nervous systemDRKS00015307niversitätsklinikum Freiburg200
Recruiting
Not Applicable
Circulating Tumour DNA as a Sensitive and Specific Marker of Response to Therapy and of Occult Disease in Colorectal CancerPatients with resectable colorectal cancer liver metastasesCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12612000345886udwig Institute for Cancer Research100
Recruiting
Not Applicable
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patientsmetastatic prostate cancerNL-OMON24467Erasmus Medical Center95
Not yet recruiting
Not Applicable
Fluid phase biopsy (circulating tumour DNA and serum tumour markers) in patients with non-small cell lung cancer.lung cancernon-small cell lung cancer10038666NL-OMON45168Antoni van Leeuwenhoek Ziekenhuis1,190